Keywords: eurand, gsk, sign, 42m, tablet, deal, italian
Eurand and GSK sign $42M tablet R&D deal
Article | 16 October 2006
Italian specialty drugmaker Eurand says that it has established a development and licensing agreement with UK-based drug major GlaxoSmithKline, under ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
